TGFB1 and neoplasm: The findings from the study highlighted a loss of the activation of ERK by TGF-β1, suggesting that TGF-β1 is involved in the inhibition of tumor growth in HT-29, the induction of apoptosis by ROS production and that this event is upstream of ERK activation [90].